CXC-Chemokine Ligand 10 in Idiopathic Pulmonary Arterial Hypertension: Marker of Improved Survival
- 26 February 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Lung
- Vol. 188 (3), 191-197
- https://doi.org/10.1007/s00408-010-9232-9
Abstract
CXC-chemokine ligand 10 (CXCL10) inhibits angiogenesis and attracts activated T lymphocytes. Abnormal angiogenesis and lymphocytic infiltration participate in the pathobiology of pulmonary arterial hypertension (PAH). We hypothesized that serum CXCL10 is elevated in idiopathic PAH and that it is associated with clinical outcomes. This was a cohort study that included 40 idiopathic PAH patients (age = 44 ± 14 years, 37 females) and 22 healthy controls (age = 35 ± 6 years, 18 females). It took place at the Pulmonary Vascular Program at the Cleveland Clinic. Serum CXCL10 levels were measured by an enzyme-linked immunosorbent assay. A cutoff value of CXCL10 for best distinguishing alive and dead patients was obtained from a receiver operating characteristic curve (ROC). Survival and time to clinical worsening curves according to the appropriate CXCL10 level were derived by the Kaplan–Meier method and compared by means of the log-rank test. The prognostic value of CXCL10 and of other variables of interest was tested by Cox proportional hazards regression analysis. Serum CXCL10 levels were elevated in PAH subjects compared to controls [CXCL10 pg/ml (mean ± SEM) for PAH: 306 ± 73, and for controls: 92 ± 10; p < 0.0001]. CXCL10 levels higher than 111 pg/ml discriminated survivors from nonsurvivors with a sensitivity of 81% and a specificity of 75% (area under the ROC curve = 0.74). After a mean follow-up of 23.5 ± 13.5 months since the day of venous sampling, higher CXCL10 levels were associated with improved survival (hazard ratio for mortality = 0.10, 95% confidence interval = 0.01–0.97; p = 0.01). Serum CXCL10 is elevated in PAH and this is associated with improved survival.This publication has 75 references indexed in Scilit:
- Sub-cellular proteomics of Medicago truncatulaFrontiers in Plant Science, 2013
- Plant Cell Organelle Proteomics in Response to Abiotic StressJournal of Proteome Research, 2011
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)European Heart Journal, 2009
- The Cancer Paradigm of Severe Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Absence of T Cells Confers Increased Pulmonary Arterial Hypertension and Vascular RemodelingAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Medicago truncatulaRoot Nodule Proteome Analysis Reveals Differential Plant and Bacteroid Responses to Drought StressPlant Physiology, 2007
- Characterization of Lipid Rafts from Medicago truncatula Root Plasma Membranes: A Proteomic Study Reveals the Presence of a Raft-Associated Redox SystemPlant Physiology, 2007
- Finishing the euchromatic sequence of the human genomeNature, 2004
- Mass spectrometry-based proteomicsNature, 2003
- Interferon γ-Inducible Protein-10 (IP-10), a Member of the C-X-C Chemokine Family, Is an Inhibitor of AngiogenesisBiochemical and Biophysical Research Communications, 1995